Autopsy report · NCT01623271

Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Due to limited population of research participants.”

The sponsor’s own words in the registry.

Life of this trial

Registered 11 months before it started.
Ran for about 1 year 1 month before it stopped.
5 participants enrolled.
Results were posted on the registry 2 years 10 months after it ended.

Vital statistics

Status: Terminated
Phase: Na
Sponsor: Massachusetts General Hospital
Sponsor type: University, hospital or other
Conditions: Complex Regional Pain Syndrome I (CRPS I)
Interventions: Gabapentin
Participants: 5
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.